DGI001

Home parenteral nutrition: Patients´ satisfaction to the attention given by the Hospital Pharmacy Service

DGI002

Study of the use of linezolid in outpatients and patients admitted in the hospital, except in intensive care unit

DGI003

Analysis of empirical antibiotic therapy in emergency department and follow up in general medicine department

DGI004

Zoledronic acid: Evaluation of drug use in a general hospital

DGI005

Efficacy and safety of intravenous fentanyl in a palliative care unit

DGI006

Parenteral nutrition suplemented with glutamin in haematological patients undergoing peripheral blood stem cell transplant

DGI007

Stability study of doripenem for continuous infusion

DGI008

ANTIBIOTIC PRESCRIBING IN CLINICAL HOSPITAL CENTER OSIJEK DURING THE PERIOD 2004-2009

DGI009

HIV-positive patients clinical and therapeutic path: a multidisciplinary team in Amedeo di Savoia hospital

DGI010

BORTEZOMIB FOR MULTIPLE MYELOMA: RESULTS OF 2 YEARS OF MONITORING

DGI011

Guide for handling queries about administration of drugs through enteral tubes developed by The Medicine Information Centre.

DGI012

Accidental subcutaneous administration of intravenous infusions: An inquiry answering guideline

DGI013

Correlation between case-mix and antibiotic consumption in a tertiary hospital

DGI014

ADEQUACY OF EMPIRICAL ANTIBIOTIC TREATMENTS IN CLINICAL PRACTICE

DGI015

Reduction of bevacizumab infusion time

DGI016

Use of bevacizumab and cetuximab in colorectal cancer treatment in a Portuguese general hospital

DGI017

Development of a web-based antimicrobial resource to improve antimicrobial prescribing – a two year review

DGI018

Intraocular recombinant tissue plasminogen activator: a case report

DGI019

Compliance of the antibiotics policy in a general hospital

DGI020

Effectiveness and safety of azacitidine in the treatment of patients with myelodysplastic syndromes and acute myeloid leukemia

DGI021

Bevacizumab in recurrent glioblastoma

DGI022

Safety of azacitidine in patients with myelodysplastic syndromes

DGI023

L-asparaginase from Erwinia chrysanthemi: an alternative in patients with hypersensitivity to L-asparaginase from Escherichia coli

DGI024

Study concerning the antibiotic resistance phenotypes of some bacterial species with nosocomial potential

DGI025

Effectiveness and safety of Entecavir and Tenofovir in patients with chronic hepatitis B

DGI026

Assessment of lung cancer treatment

DGI027

Prevention of bronchiolitis in an infant with congenital heart disease: the effectiveness of palivizumab

DGI028

Clinical use of linezolid:Retrospective study at the University Hospital of Limoges (France)

DGI029

Safety experience with lenalidomide in multiple myeloma

DGI030

Evaluation of patients' knowledge on medication dispensed in an outpatient pharmaceutical care unit

DGI031

Dutch standardised reference work on manipulation of oral dosage forms

DGI032

MANAGEMENT INNOVATIONS IN THE PHARMACOTHERAPY OF MEDICAL ONCOLOGY UNIT ATTACHED IN A GENERAL HOSPITAL BASIC

DGI033

ECONOMIC ANALYSIS OF THE MANAGEMENT OF MEDICAL ONCOLOGY UNIT ATTACHED IN A BASIC GENERAL HOSPITAL

DGI034

Darunavir/ritonavir monotherapy for the treatment of HIV infection

DGI035

Lopinavir/ritonavir monotherapy as a simplification strategy in the treatment of HIV infection

DGI036

Pemetrexed as second-line treatment of advanced non-small-cell Lung Cancer

DGI037

Restricted Antibiotics Management

DGI038

Analysis of medical prescriptions containing high-cost antibiotics to treat pneumonia in hospital with the aim of assuring community-hospital continuity

DGI039

ANALYSIS OF THE 'PROTOCOLES OF TOXICITY PROPHYLAXIS' OF CHEMOTHERAPY SCHEMES USING TAXANES

DGI040

Lenalidomide: adverse events review after two years of experience

DGI041

ANALYSIS OF THE 'PROTOCOLES OF TOXICITY PROPHYLAXIS' OF CHEMOTHERAPY SCHEMES USING PLATINUM

DGI042

INTRAVENOUS INMUNOGLOBULIN: USE IN PAEDIATRIC PATIENTS

DGI043

Experience of the use of trabectedin in a teaching hospital

DGI044

study of use of raltegravir in HIV patients

DGI045

Study of Cetuximab's uses in a general hospital

DGI046

Erlotinib monotherapy as first-line treatment for stage IV lung adenocarcinoma

DGI047

Study concerning the efficiency of antibiotics in treatment of suppurative ear infections produced by Staphylococcus aureus

DGI048

Study concerning the antibiotic therapy in suppurative ear infections caused by Pseudomonas aeruginosa

DGI049

Utilization of study granulocyte-colony stimulating factor in onco-haematologic outpatien

DGI050

Primary prophylaxis of febrile neutropenia with granulocyte colony stimulating factor in onco-haematologic patients

DGI051

Delayed introduction at reduced dose of prolonged release tacrolimus in kidney transplants treated with quadruple immunosuppressive therapy